Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 427.67B | 427.67B | 433.85B | 377.30B | 334.79B | 328.36B |
Gross Profit | 170.67B | 170.67B | 159.82B | 142.48B | 130.80B | 125.22B |
EBITDA | 16.76B | 17.98B | 26.28B | 18.85B | 17.02B | 12.43B |
Net Income | 4.54B | 4.54B | 10.90B | 5.68B | 5.99B | -752.00M |
Balance Sheet | ||||||
Total Assets | 252.81B | 252.81B | 231.13B | 201.80B | 174.38B | 169.74B |
Cash, Cash Equivalents and Short-Term Investments | 60.09B | 60.09B | 54.98B | 44.29B | 45.60B | 51.87B |
Total Debt | 118.05B | 118.05B | 98.79B | 80.21B | 59.07B | 52.13B |
Total Liabilities | 162.34B | 162.34B | 143.78B | 124.59B | 97.18B | 96.76B |
Stockholders Equity | 90.40B | 90.40B | 87.31B | 77.21B | 77.19B | 72.98B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -3.11B | 151.00M | -3.38B | -12.25B | 5.25B |
Operating Cash Flow | 0.00 | 8.01B | 9.30B | 4.28B | -5.73B | 12.43B |
Investing Cash Flow | 0.00 | -12.49B | -10.40B | -9.59B | -6.69B | -8.22B |
Financing Cash Flow | 0.00 | 10.78B | 12.40B | 3.94B | 5.59B | 14.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥25.32B | 11.57 | 4.19% | 8.63% | -3.75% | ||
73 Outperform | ¥11.87B | 11.22 | 3.60% | 2.27% | 33.92% | ||
73 Outperform | ¥44.69B | 15.70 | 1.91% | 19.76% | 11.62% | ||
63 Neutral | ¥66.10B | 19.27 | 2.04% | 1.10% | -64.41% | ||
61 Neutral | $17.99B | 12.87 | -3.58% | 2.97% | 1.27% | -14.28% | |
55 Neutral | ¥12.91B | ― | 1.04% | -0.79% | -107.47% | ||
― | ¥26.69B | 14.01 | 1.60% | ― | ― |